证券研究报告——晨会聚焦 2025 年 8 月 1 日 | 市场指数 | | | | --- | --- | --- | | 指数名称 | 收盘价 | 涨跌% | | 上证综指 | 3573.21 | (1.18) | | 深证成指 | 11009.77 | (1.73) | | 沪深 300 | 4075.59 | (1.82) | | 中小 100 | 6833.61 | (1.84) | | 创业板指 | 2328.31 | (1.66) | 行业表现（申万一级） | 指数名称 | 涨跌% | 指数名称 | 涨跌% | | --- | --- | --- | --- | | 计算机 | 0.39 | 钢铁 | (4.08) | | 通信 | 0.06 | 有色金属 | (3.19) | | 综合 | (0.29) | 房地产 | (3.14) | | 国防军工 | (0.39) | 煤炭 | (2.72) | | 银行 | (0.50) | 非银金融 | (2.57) | 资料来源：万得，中银证券 中银晨会聚焦-20250801 ■重点关注 【宏观经济】"十四五"收官，"十五五"开局*张晓娇 朱启兵。中 ...

Group 1 - The company Xingwang Ruijie (SZ 002396) announced an investor research meeting scheduled for July 31, 2025, at 10:00 AM, where key executives will participate in addressing investor inquiries [2] - For the year 2024, the company's revenue composition is entirely from the telecommunications equipment manufacturing sector, accounting for 100.0% [2]

Group 1 - The company Baoming Technology (002992) expects a net loss attributable to shareholders of between 12 million to 15 million yuan for the first half of 2025, compared to a loss of 46.40 million yuan in the same period last year, representing a reduction in loss of 67.67% to 74.14% [1] - The expected net loss after deducting non-recurring gains and losses is projected to be between 10 million to 13 million yuan, down from a loss of 53.82 million yuan in the previous year, indicating a reduction in loss of 75.85% to 81.42% [1] - From 2021 to 2024, the company reported net losses of 354 million yuan, 223 million yuan, 124 million yuan, and 76.35 million yuan respectively, with non-recurring losses of 364 million yuan, 238 million yuan, 126 million yuan, and 84.74 million yuan [1] Group 2 - Baoming Technology raised a total of 771 million yuan from its initial public offering, with a net amount of 707 million yuan after deducting issuance costs [2] - The company plans to use the raised funds for the expansion of LED backlight sources, capacitive touch screen production, and the establishment of a research and development center [2] - The company's 2020 annual equity distribution plan included a cash dividend of 3.7 yuan per 10 shares, totaling 51.05 million yuan, and a capital reserve increase of 3 shares for every 10 shares held, increasing the total share capital to 179.35 million shares [2]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 根据万家基金管理有限公司（以下简称"本公司"）分别与中航证券有限公司、民生证券股份有限公司、 中银国际证券股份有限公司、天风证券股份有限公司、上海证券有限责任公司、德邦证券股份有限公 司、东吴证券股份有限公司、东方证券股份有限公司、华鑫证券有限责任公司、华创证券有限责任公 司、申万宏源证券有限公司、申万宏源西部证券有限公司、东兴证券股份有限公司、湘财证券股份有限 公司、第一创业证券股份有限公司、诚通证券股份有限公司以及开源证券股份有限公司（以下合称"上 述机构"）签订的销售协议，本公司自2025年7月28日起新增上述机构办理万家稳康30天持有期债券型证 券投资基金（简称：万家稳康30天持有期债券；基金代码：A类：024530，C类：024531）的销售业 务。万家稳康30天持有期债券自2025年7月28日至2025年8月8日通过基金管理人指定的销售机构公开发 售，投资者可在上述机构办理万家稳康30天持有期债券的开户及认购业务，待基金成立后也可办理申 购、赎回及定投等其他业务，具体费率以上述机构公告为准，具体办理程序请遵循上述机构的相关规 ...

Summary of Key Points Core Viewpoint - The stock of Sely Medical (603716) experienced a significant increase of 9.86% on the trading day, with a turnover rate of 41.30% and a total transaction value of 1.799 billion yuan, indicating strong market interest and trading activity [2]. Trading Activity - The stock was listed on the Shanghai Stock Exchange's "龙虎榜" due to a daily turnover rate of 40.85%, with a net buying amount of 6.0667 million yuan from brokerage seats [2]. - The top five brokerage seats accounted for a total transaction value of 464 million yuan, with a buying transaction value of 235 million yuan and a selling transaction value of 229 million yuan, resulting in a net buying of 6.0667 million yuan [2]. - The largest buying and selling brokerage was Guotai Junan Securities Co., Ltd. headquarters, with buying amounting to 69.4307 million yuan and selling amounting to 95.7336 million yuan [2]. Historical Performance - Over the past six months, the stock has appeared on the "龙虎榜" 23 times, with an average price increase of 0.93% the day after being listed and an average increase of 3.90% over the following five days [2]. Capital Flow - On the trading day, the stock saw a net inflow of 242 million yuan from major funds, with a net inflow of 171 million yuan from large orders and 70.8008 million yuan from medium orders [2]. - In the past five days, the net inflow of major funds totaled 85.3307 million yuan [2]. Financial Performance - According to the Q1 report released on April 29, the company achieved a revenue of 287 million yuan, representing a year-on-year decline of 40.75%, and reported a net loss of 14.3209 million yuan [2].

本次减持计划自公告披露之日起15个交易日后的3个月内实施，且在任意连续90日内，以集中竞价交易 方式减持的股份数量不超过公司股份总数的1.00%；以大宗交易方式减持的股份数量不超过公司股份总 数的2.00%。 在减持计划实施期间，公司若发生派发红利、送红股、资本公积金转增股本、回购股份注销、增发新股 或配股等股份变动事项，上述减持数量将进行相应调整。 截止公告披露日，周建清直接持有公司股份67,732,718股，占公司股份总数的32.08%。周建清不存在一 致行动人。 中国经济网北京6月19日讯上海沿浦（605128）(605128.SH)昨晚披露的关于控股股东、实际控制人减持 股份计划的公告显示，公司控股股东、实际控制人周建清因个人资金需求，拟通过集中竞价交易方式减 持其所持有的公司股份合计不超过2,110,000股，即不超过公司股份总数的0.9993%，拟通过大宗交易方 式减持其所持有的公司股份合计不超过4,220,000股，即不超过公司股份总数的1.9987%，周建清本次合 计减持不超过公司股份总数的2.9980%。 上海沿浦本次发行费用合计5212.27万元，其中保荐机构中银国际证券股份有限公司获得承 ...

Core Viewpoint - The announcement details the share pledge situation of the controlling shareholder, Lao Bai Xi Medicine Group, which holds 26.12% of the total shares of Lao Bai Xi Pharmacy Chain Co., Ltd. and has pledged 137,950,000 shares, accounting for 18.15% of the total share capital [1] Summary by Sections Share Pledge of Listed Company - The controlling shareholder, Lao Bai Xi Medicine Group, has pledged part of its shares, with the pledgee being Bank of China International Securities Co., Ltd. The pledged shares amount to 1,235,000 shares, with a pledge start date of June 5, 2025, and an expiration date of June 4, 2026 [1] Cumulative Pledge Situation of Controlling Shareholder and Concerted Actors - As of the announcement date, the cumulative pledge situation of the controlling shareholder and concerted actors is as follows: Lao Bai Xi Medicine Group holds 198,564,175 shares (26.12%), with 137,950,000 shares pledged (69.47% of its holdings, 18.15% of total shares) [2][5] Pledge Risk Management - The company indicates that the pledge risk is controllable, with future repayment sources primarily from dividends, investment income, and self-raised funds. In case of margin call risks, the group will take measures such as additional pledges or early repayments [5]

Group 1 - The issuer of the bond is China National Railway Group Co., Ltd., with a total issuance scale of 10 billion yuan for the "2025 Sixth Phase China Railway Construction Bond" [17][13] - The bond is divided into two types: a 10-year bond with a scale of 5 billion yuan and a 30-year bond with a scale of 5 billion yuan, totaling 10 billion yuan [17] - The bond will adopt a fixed interest rate, with the 10-year bond's annual interest rate being the Shibor benchmark rate plus a basic spread ranging from -0.4% to 0.6%, and the 30-year bond's annual interest rate ranging from -0.3% to 0.7% [17] Group 2 - The bond issuance will be conducted through a bidding system provided by the Shenzhen Stock Exchange, targeting institutional investors [18] - The bond will be issued at par value of 100 yuan, with a minimum subscription amount of 10 million yuan [18] - The bidding date is set for May 27, 2025, with the payment deadline on May 28, 2025 [19][20] Group 3 - The bond will be registered and custodied by the China Securities Depository and Clearing Corporation Limited and the Central National Debt Registration and Clearing Co., Ltd. [18] - The interest payment will occur annually, with the first interest payment starting from May 28, 2025 [20] - The bond will not compound interest, and any overdue interest will not be calculated [20]

Monetary Policy Adjustments - The central bank has implemented a 0.5% reduction in the reserve requirement ratio, expected to provide approximately 1 trillion yuan in long-term liquidity to the market[2] - A policy interest rate cut of 0.1% has been enacted, lowering the 7-day reverse repurchase rate from 1.50% to 1.40%, which is anticipated to lead to a similar decrease in the Loan Prime Rate (LPR) by about 0.1%[2] - The interest rate for structural monetary policy tools has been reduced by 0.25%, including various special structural tools and the re-lending rate for agriculture and small enterprises, from 1.75% to 1.50%[2] Support for Consumption and Innovation - The reserve requirement ratio for auto finance and leasing companies will be temporarily lowered from 5% to 0%, aimed at boosting auto consumption[2] - A new 500 billion yuan "service consumption and pension re-lending" facility has been established to enhance credit support for service consumption and reduce housing loan burdens[2] - The government plans to increase the re-lending quota for technological innovation and transformation by 300 billion yuan, raising the total to 800 billion yuan[2] Capital Market Stability - A combined total of 800 billion yuan will be allocated for securities fund and insurance company swap facilities and stock repurchase loans[2] - The risk factor for insurance company stock investments has been lowered to 10%, promoting stability and activity in the capital market[2] - The government is expediting the release of revised regulations for major asset restructuring of listed companies to enhance capital market merger and acquisition channels[2] Economic Outlook and Risks - The GDP growth rate for Q1 was reported at 5.4%, indicating a need for monetary policy easing to address economic weaknesses[2] - Upcoming trade talks with the U.S. are expected to strengthen China's negotiating position, coinciding with a favorable window for monetary policy easing due to anticipated U.S. interest rate cuts[2] - Risks include potential global inflation resurgence, rapid economic downturns in Europe and the U.S., and increasing international geopolitical complexities[2]

Core Viewpoint - The company is actively engaging in research and development, focusing on integrating advanced technologies such as DeepSeek into its products, while also navigating challenges such as rising costs and international trade issues. Group 1: Financial Performance - In Q1 2025, the company reported a main revenue of 80.79 million yuan, an increase of 7.01% year-on-year, while the net profit attributable to shareholders decreased by 48.44% to 7.97 million yuan [7] - The company's gross profit margin stands at 60.18%, with a debt ratio of 15.37% [7] Group 2: Cost Management - The increase in expenses for 2024 is attributed to enhanced R&D, sales team development, and market expansion, leading to higher personnel costs, business entertainment, and travel expenses [2] - The company has implemented a comprehensive budget management mechanism to align resources with strategic goals and performance targets [2] Group 3: Technological Integration - The company has successfully integrated its edge gateway with the DeepSeek model, enabling real-time semantic understanding and inference of heterogeneous data [3] - This integration allows for automatic identification of equipment anomalies and enhances operational efficiency in industrial scenarios [3] Group 4: Industry Outlook - The coal mining industry is expected to see stable growth, driven by national policies aimed at achieving full automation and smart systems by 2035 [4] - The company anticipates significant opportunities in the coal mining sector as the government pushes for intelligent mining solutions [4] Group 5: International Trade Impact - The company assesses that the impact of the US-China tariff situation is manageable, as overseas revenue is not significantly high, and strategic reserves for chips have been established [5] - Potential indirect effects on clients due to tariffs are acknowledged, but overall, the impact is considered controllable [5] Group 6: Market Expansion - The company plans to strengthen its presence in emerging markets like Southeast Asia and the Middle East while also increasing efforts in mature markets such as Europe and the US [6] - Localized sales and service teams will be established to better understand and meet local market demands [6]